Association Between the -11377 C/G and -11391 G/A Polymorphisms of Adiponectin Gene and Adiponectin Levels with Susceptibility to Type 1 and Type 2 Diabetes Mellitus in Population from the West of Iran, Correlation with Lipid Profile
Overview
Cell Biology
Authors
Affiliations
Adipose tissue, an endocrine organ, secretes bioactive factors including adiponectin. Adiponectin is a protein hormone that enhances insulin sensitivity through increased fatty acid oxidation and inhibition of hepatic glucose production. We assessed the association of the adiponectin promoter region polymorphisms -11391 G/A and -11377 C/G with susceptibility to type 1 (T1DM) and type 2 (T2DM) diabetes mellitus in the population of west Iran. Also, we investigated the effect of adiponectin level and lipid profile on T1DM and T2DM development. In this case-control study, we recruited 189 patients with diabetes (100 T2DM and 89 T1DM) and 161 sex and age-matched unrelated healthy controls. Adiponectin mutations were detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), and the protein level was measured by the enzyme-linked immunosorbent assay. Other biochemical parameters were determined by routine laboratory methods. The G allele of adiponectin gene at -11377 position (C/G) significantly increased the risk of T1DM. With respect to genotype models, codominant (2.97 times), dominant (3.6-fold), and over-codominant (2.9-fold) patients with T1DM who carried -11377 C > G single-nucleotide polymorphisms were significantly susceptible to the development of the disease. A significantly higher level of adiponectin in T1DM was oberved compared with the control group. In contrast, patients with T2DM had lower adiponectin levels compared with healthy controls. The genotype distributions of -11391 G/A polymorphisms were the same for patients with diabetes and control groups. The presence of G allele at -11377 C/G adiponectin gene significantly increased serum adiponectin level and may be a risk factor for T1DM susceptibility among the western Iranian population.
Bakr N, Hashim N, Ibrahim N, Saadawy S Sci Rep. 2025; 15(1):3872.
PMID: 39890883 PMC: 11785776. DOI: 10.1038/s41598-025-86143-3.
Tangjittipokin W, Narkdontri T, Teerawattanapong N, Thanatummatis B, Wardati F, Sunsaneevithayakul P J Multidiscip Healthc. 2023; 16:309-319.
PMID: 36748054 PMC: 9899009. DOI: 10.2147/JMDH.S396238.
Wu J, Wang X, Chen H, Yang R, Yu H, Wu Y Metabolites. 2022; 12(9).
PMID: 36144279 PMC: 9502507. DOI: 10.3390/metabo12090875.
Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population.
Akhlaghipour I, Bina A, Mogharrabi M, Fanoodi A, Ebrahimian A, Khojasteh Kaffash S Hum Genomics. 2022; 16(1):11.
PMID: 35366956 PMC: 8976361. DOI: 10.1186/s40246-022-00383-2.
Adiponectin gene polymorphisms and risk of type 2 diabetes: an updated evidence for meta-analysis.
Alimi M, Goodarzi M, Nekoei M Diabetol Metab Syndr. 2021; 13(1):133.
PMID: 34789338 PMC: 8596906. DOI: 10.1186/s13098-021-00749-x.